# Reducing Lung CongestIon Symptoms in Advanced Heart Failure

Study · id `cardio:ct-nct03499236` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03499236](<https://clinicaltrials.gov/study/NCT03499236>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03499236

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 605 participants.

## Technical summary

Registry record NCT03499236. Randomized; quadruple masking; primary purpose treatment. Start 2018-09-19 (actual); primary completion 2023-10-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 605 participants (enrolled count; ClinicalTrials.gov record NCT03499236, source copy `cardio:ctgov-nct03499236-2025-08-19`, retrieved 2026-10-26)
- Started: 2018-09-19 (actual) (ClinicalTrials.gov record NCT03499236, source copy `cardio:ctgov-nct03499236-2025-08-19`, retrieved 2026-10-26)
- Primary completion: 2023-10-09 (actual) (ClinicalTrials.gov record NCT03499236, source copy `cardio:ctgov-nct03499236-2025-08-19`, retrieved 2026-10-26)
- Completion: 2027-10-31 (anticipated) (ClinicalTrials.gov record NCT03499236, source copy `cardio:ctgov-nct03499236-2025-08-19`, retrieved 2026-10-26)
- Countries: United States; Australia; Belgium; Canada; Germany; Israel; Netherlands; New Zealand; Poland; Spain; Switzerland (ClinicalTrials.gov record NCT03499236, source copy `cardio:ctgov-nct03499236-2025-08-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03499236-2025-08-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Reducing Lung CongestIon Symptoms in Advanced Heart Failure
- Acronym: RELIEVE-HF
- Condition: Heart Failure
- Intervention (Device): V-Wave Interatrial Shunt
- Intervention (Other): Control
- Lead sponsor: V-Wave Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial (`cardio:pubmed-39308371`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Mechanistic Basis for Differential Effects of Interatrial Shunt Treatment in HFrEF vs HFpEF: The RELIEVE-HF Trial (`cardio:pubmed-40892630`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 93ad51219e71cc9951960ede1924eb9394538e1e17e24cc46b2b52688a99abee
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
